首页> 外文期刊>Urology >Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy.
【24h】

Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy.

机译:枸酸西地那非和真空收缩装置的组合可增强前列腺癌根治术后勃起功能障碍中的性满足感。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To assess the effectiveness of combining sildenafil citrate with a vacuum constriction device (VCD) in men (after radical prostatectomy) unsatisfied with the results of the VCD alone. METHODS: A total of 31 patients unsatisfied with the early use of VCD alone after radical prostatectomy (mean follow-up of 4.5 months) were instructed to take 100 mg of sildenafil 1 to 2 hours before VCD use for sexual intercourse. Patients used combination therapy for a minimum of five attempts before assessment with the abridged International Index of Erectile Function (IIEF) questionnaire and a visual analogue scale to gauge rigidity. The effect of combination therapy on the total IIEF-5 score and penile rigidity score were assessed. RESULTS: Of the 31 patients, 7 (22%) had no improvement with the addition of sildenafil with VCD and discontinued the drug, and 24 (77%) reported improved penile rigidity and sexual satisfaction. The IIEF-5 score revealed statistically significant improvement in each domain, and patients reported that sildenafil enhanced their erections 100% of the time. The penile rigidity scores on a scale of 0 to 100 with the VCD alone averaged 55% (range 23% to 85%) for the men and 59% (range 26% to 90%) for their partners. With the addition of sildenafil, it increased to 76% for the men and 82% for their partners. Of the 24 men, 7 (30%) reported a return of natural erections at 18 months using combination therapy, with 5 of 7 reporting erections sufficient for vaginal penetration. CONCLUSIONS: In this study, the addition of sildenafil with VCD improved sexual satisfaction and penile rigidity in patients unsatisfied with VCD alone after radical prostatectomy.
机译:目的:评估将枸sil酸西地那非与真空压缩装置(VCD)结合使用对男性(单用VCD的结果仍不满意)的有效性。方法:共有31例患者接受了前列腺癌根治术后单次使用VCD的不满意治疗(平均随访4.5个月),并被要求在VCD使用前1到2小时服用西地那非100 mg。患者在使用国际勃起功能指数(IIEF)问卷和视觉模拟量表进行评估之前,至少要进行五次联合治疗,以评估其刚度。评估联合治疗对IIEF-5总评分和阴茎僵硬度评分的影响。结果:31例患者中,有7例(22%)在使用昔多芬和VCD的情况下无改善,并停用了该药;还有24例(77%)的阴茎僵硬和性满意度得到改善。 IIEF-5分数显示出每个领域的统计学显着性改善,并且患者报告西地那非可100%地增强勃起。单独使用VCD时,男性的阴茎刚度评分平均为55%(范围为23%至85%),伴侣为59%(范围为26%至90%)。随着西地那非的添加,男性增加到76%,伴侣增加到82%。在24名男性中,有7名(30%)报告称使用联合疗法在18个月后自然勃起恢复,其中7名中有5名报告勃起足以穿透阴道。结论:在这项研究中,西地那非与VCD的结合可改善前列腺癌根治术后单视VCD不满意的患者的性满意度和阴茎僵硬。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号